Chen-Hsin Albert Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Chen-Hsin Albert Yu has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Wendy W. Hwang-Verslues
Genomics Research Center, Academia Sinica, Taipei, Taiwan
12 shared publications - Li-Tzu Cheng
Genomics Research Center, Academia Sinica, Taipei, Taiwan
11 shared publications - Grace Y. T. Tan
Molecular and Cell Biology, Taiwan International Graduate Program, Academia Sinica and National Defense Medical University, Taipei, Taiwan
10 shared publications - Cheng-Kai Wang
Genomics Research Center, Academia Sinica, Taipei, Taiwan
9 shared publications - Fang-Pei Chang
Genomics Research Center, Academia Sinica, Taipei, Taiwan
9 shared publications - Samyuktha Sridharan
Genomics Research Center, Academia Sinica, Taipei, Taiwan
9 shared publications
Latest Publications
- Open Access
- 24 August 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123  (35)
A dominant mutation in tomato DNA POLYMERASE DELTA 1 causes geminivirus DNA replication catastrophe
Geminiviruses pose a severe threat to grain and vegetable crops worldwide, often resulting in significant economic losses. In cultivated tomato ( Solanum lycopersicum ), Ty resistance alleles have been introduced from wild tomato relatives, providing partial to strong resistance to geminivirus infections. The Ty-6 resistance locus from Solanum chilense was previously mapped to chromosome 10. It was recently shown to contain a mutant allele of the DNA POLYMERASE DELTA 1 ( POLD1 ) gene that provides resistance to Tomato yellow leaf curl virus (TYLCV) infections. However, the resistance mechanism remained unknown. Here, we report another POLD1 allele at the Ty-6 locus of S. chilense with an E622D mutation in the catalytic site of the POLD1 protein. POLD1 E622D is maintained as a heterozygous dominant allele in S. chilense and the AVTO2225 breeding line. It provides full resistance to the severe TYLCV Thailand (TYLCTHV) strain. The E622D amino acid change does not alter the predicted structure of POLD1. Replication of the TYLCTHV genome in plants carrying the POLD1 E622D allele is severely compromised by a high frequency of mutations that accumulate in viral DNA, which results in nonfunctional proteins that are essential for continuous viral replication. Ectopically expressing the POLD1 E622D allele cDNA alone causes mutations in TYLCTHV genes in inoculated leaves. S. chilense and AVTO2225 plants carrying the POLD1 E622D allele mount a hypersensitive response after TYLCTHV infection, indicating that the defective virus genome cannot suppress the plant defense. The dominant POLD1 E622D allele is therefore an effective resistance gene that geminiviruses cannot overcome.
- 24 August 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123  (35)
Open AccessA dominant mutation in tomato DNA POLYMERASE DELTA 1 causes geminivirus DNA replication catastrophe
Geminiviruses pose a severe threat to grain and vegetable crops worldwide, often resulting in significant economic losses. In cultivated tomato ( Solanum lycopersicum ), Ty resistance alleles have been introduced from wild tomato relatives, providing partial to strong resistance to geminivirus infections. The Ty-6 resistance locus from Solanum chilense was previously mapped to chromosome 10. It was recently shown to contain a mutant allele of the DNA POLYMERASE DELTA 1 ( POLD1 ) gene that provides resistance to Tomato yellow leaf curl virus (TYLCV) infections. However, the resistance mechanism remained unknown. Here, we report another POLD1 allele at the Ty-6 locus of S. chilense with an E622D mutation in the catalytic site of the POLD1 protein. POLD1 E622D is maintained as a heterozygous dominant allele in S. chilense and the AVTO2225 breeding line. It provides full resistance to the severe TYLCV Thailand (TYLCTHV) strain. The E622D amino acid change does not alter the predicted structure of POLD1. Replication of the TYLCTHV genome in plants carrying the POLD1 E622D allele is severely compromised by a high frequency of mutations that accumulate in viral DNA, which results in nonfunctional proteins that are essential for continuous viral replication. Ectopically expressing the POLD1 E622D allele cDNA alone causes mutations in TYLCTHV genes in inoculated leaves. S. chilense and AVTO2225 plants carrying the POLD1 E622D allele mount a hypersensitive response after TYLCTHV infection, indicating that the defective virus genome cannot suppress the plant defense. The dominant POLD1 E622D allele is therefore an effective resistance gene that geminiviruses cannot overcome.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis
RNAseq: Gene expression fold-change between sh-MEX3A and sh-Ctrl
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis
RNAseq: Gene expression fold-change between sh-MEX3A and sh-Ctrl
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1-S5, Table S1 from MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis
Table S1. Short tandem repeat of ovarian teratocarcinoma and clear cell carcinoma cell line. Figure S1. MEX3A expression promoted tumorigenic ability and cell survival in WT p53 OC cells. Figure S2. The p53 pathway was enriched in upregulated genes in MEX3A-depleted OC cells expressing WT p53. Figure S3. Stabilized WT p53 protein in MEX3A-depleted cells was activated. MEX3A did not interact with or affect the level of mutant p53 protein. Figure S4. p53 depletion alone did not significantly affect cell proliferation or cell death in MEX3A expressing WT p53 OC cells. Figure S5. MEX3A and MDM2 in OC.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1-S5, Table S1 from MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis
Table S1. Short tandem repeat of ovarian teratocarcinoma and clear cell carcinoma cell line. Figure S1. MEX3A expression promoted tumorigenic ability and cell survival in WT p53 OC cells. Figure S2. The p53 pathway was enriched in upregulated genes in MEX3A-depleted OC cells expressing WT p53. Figure S3. Stabilized WT p53 protein in MEX3A-depleted cells was activated. MEX3A did not interact with or affect the level of mutant p53 protein. Figure S4. p53 depletion alone did not significantly affect cell proliferation or cell death in MEX3A expressing WT p53 OC cells. Figure S5. MEX3A and MDM2 in OC.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Data from MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis
Epithelial ovarian cancer is a highly heterogeneous and malignant female cancer with an overall low survival rate. Mutations in p53 are prevalent in the major ovarian cancer histotype, high-grade serous ovarian carcinoma (HGSOC), while p53 mutations are much less frequent in other ovarian cancer subtypes, particularly in ovarian clear cell carcinoma (OCCC). Advanced stage OCCC with wild-type (WT) p53 has a worse prognosis and increased drug resistance, metastasis, and recurrence than HGSOC. The mechanisms responsible for driving the aggressiveness of WT p53-expressing ovarian cancer remain poorly understood. Here, we found that upregulation of MEX3A, a dual-function protein containing a RING finger domain and an RNA-binding domain, was critical for tumorigenesis in WT p53-expressing ovarian cancer. MEX3A overexpression enhanced the growth and clonogenicity of OCCC cell lines. In contrast, depletion of MEX3A in OCCC cells, as well as ovarian teratocarcinoma cells, reduced cell survival and proliferative ability. MEX3A depletion also inhibited tumor growth and prolonged survival in orthotopic xenograft models. MEX3A depletion did not alter p53 mRNA level but did increase p53 protein stability. MEX3A-mediated p53 protein degradation was crucial to suppress ferroptosis and enhance tumorigenesis. Consistently, p53 knockdown reversed the effects of MEX3A depletion. Together, our observations identified MEX3A as an important oncogenic factor promoting tumorigenesis in ovarian cancer cells expressing WT p53.Significance:Degradation of p53 mediated by MEX3A drives ovarian cancer growth by circumventing p53 tumor suppressive functions, suggesting targeting MEX3A as a potential strategy for treating of ovarian cancer expressing WT p53.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis
Epithelial ovarian cancer is a highly heterogeneous and malignant female cancer with an overall low survival rate. Mutations in p53 are prevalent in the major ovarian cancer histotype, high-grade serous ovarian carcinoma (HGSOC), while p53 mutations are much less frequent in other ovarian cancer subtypes, particularly in ovarian clear cell carcinoma (OCCC). Advanced stage OCCC with wild-type (WT) p53 has a worse prognosis and increased drug resistance, metastasis, and recurrence than HGSOC. The mechanisms responsible for driving the aggressiveness of WT p53-expressing ovarian cancer remain poorly understood. Here, we found that upregulation of MEX3A, a dual-function protein containing a RING finger domain and an RNA-binding domain, was critical for tumorigenesis in WT p53-expressing ovarian cancer. MEX3A overexpression enhanced the growth and clonogenicity of OCCC cell lines. In contrast, depletion of MEX3A in OCCC cells, as well as ovarian teratocarcinoma cells, reduced cell survival and proliferative ability. MEX3A depletion also inhibited tumor growth and prolonged survival in orthotopic xenograft models. MEX3A depletion did not alter p53 mRNA level but did increase p53 protein stability. MEX3A-mediated p53 protein degradation was crucial to suppress ferroptosis and enhance tumorigenesis. Consistently, p53 knockdown reversed the effects of MEX3A depletion. Together, our observations identified MEX3A as an important oncogenic factor promoting tumorigenesis in ovarian cancer cells expressing WT p53.Significance:Degradation of p53 mediated by MEX3A drives ovarian cancer growth by circumventing p53 tumor suppressive functions, suggesting targeting MEX3A as a potential strategy for treating of ovarian cancer expressing WT p53.
- Open Access
MEX3A control of mitochondrial fitness is essential for ovarian clear cell carcinoma tumorigenesis and liver metastasis
Ovarian cancer (OC) is highly metastatic and chemoresistant. Due to heterogeneity among OC subtypes, the mechanisms underlying OC malignancy and metastasis remain largely unknown. Ovarian clear cell carcinoma (OCCC) accounts for 5-25% of OC and its incidence rate is rising. Liver metastasis is particularly high in OCCC patients and leads to significantly reduced median survival. Why OCCC metastasizes to liver at such high frequency remains elusive. We previously identified MEX3A as a key factor that promotes OCCC tumorigenesis in part by circumventing p53-mediated ferroptosis. Here, we report that MEX3A control of mitochondrial fitness, which occurs independently of p53, is essential for OCCC primary tumor growth and liver metastasis. MEX3A depletion resulted in chronic mitochondrial fragmentation and accumulation of non-functional mitochondria. MEX3A-depleted cells had decreased mitochondrial membrane potential, increased superoxide and decreased NAD + /NADH ratio, resulting in inhibition of oxidative phosphorylation (OXPHOS) and decreased ATP levels. In an environment enriched with mitophagy stressors, such as the liver, MEX3A-depleted OCCC cells had greatly reduced survival due to failure to recover from mitophagy. Consistent with these observations, MEX3A knockdown greatly reduced liver metastasis. Together, these data demonstrate that MEX3A-mediated mitochondrial fitness is a major factor underlying its p53-independent promotion of OCCC tumorigenesis and liver metastasis. Thus, targeting MEX3A will be a promising strategy to inhibit OCCC progression. Statement of significance: Unexpected effects of MEX3A on mitochondrial fitness indicate that the need for high MEX3A expression is an OCCC vulnerability that can be exploited to uncover new treatment strategies.
Open AccessMEX3A control of mitochondrial fitness is essential for ovarian clear cell carcinoma tumorigenesis and liver metastasis
Ovarian cancer (OC) is highly metastatic and chemoresistant. Due to heterogeneity among OC subtypes, the mechanisms underlying OC malignancy and metastasis remain largely unknown. Ovarian clear cell carcinoma (OCCC) accounts for 5-25% of OC and its incidence rate is rising. Liver metastasis is particularly high in OCCC patients and leads to significantly reduced median survival. Why OCCC metastasizes to liver at such high frequency remains elusive. We previously identified MEX3A as a key factor that promotes OCCC tumorigenesis in part by circumventing p53-mediated ferroptosis. Here, we report that MEX3A control of mitochondrial fitness, which occurs independently of p53, is essential for OCCC primary tumor growth and liver metastasis. MEX3A depletion resulted in chronic mitochondrial fragmentation and accumulation of non-functional mitochondria. MEX3A-depleted cells had decreased mitochondrial membrane potential, increased superoxide and decreased NAD + /NADH ratio, resulting in inhibition of oxidative phosphorylation (OXPHOS) and decreased ATP levels. In an environment enriched with mitophagy stressors, such as the liver, MEX3A-depleted OCCC cells had greatly reduced survival due to failure to recover from mitophagy. Consistent with these observations, MEX3A knockdown greatly reduced liver metastasis. Together, these data demonstrate that MEX3A-mediated mitochondrial fitness is a major factor underlying its p53-independent promotion of OCCC tumorigenesis and liver metastasis. Thus, targeting MEX3A will be a promising strategy to inhibit OCCC progression. Statement of significance: Unexpected effects of MEX3A on mitochondrial fitness indicate that the need for high MEX3A expression is an OCCC vulnerability that can be exploited to uncover new treatment strategies.
- Open Access
BMAL2 is a druggable target for ARID1A-wildtype ovarian clear cell carcinoma (OCCC)
Ovarian clear cell carcinoma (OCCC) is highly chemo-resistant and has worse clinical outcome at advanced stages than other ovarian cancer subtypes. The most frequent (∼50%) alterations in OCCC are AT-rich interactive domain 1A gene (ARID1A) mutations which lead to ARID1A deficiency. However, OCCC that retains ARID1A function differs substantially from ARID1A mutated OCCC. Particularly, targeted therapies that sensitize ARID1A-deficient OCCC to DNA damage are largely ineffective against OCCC with wild-type (wt) ARID1A. Thus, it is important to identify druggable targets and develop targeted therapies specifically for ARID1A-wt OCCC. We identified BMAL2 as a critical OCCC oncogene that promotes tumorigenesis by preventing DNA damage from endogenous origins. BMAL2 depletion altered expression of genes in DNA damage repair pathways, including RAD51, a core enzyme of the homologous recombination (HR) pathway. This led to double-stranded break accumulation, decreased cell viability and reduced tumor growth. This dependence on BMAL2 to maintain DNA integrity and cell viability can be a new route to suppress ARID1A-wt OCCC. Consistent with this idea, we found that GW833972A, a cannabinoid receptor agonist, bound BMAL2 with high affinity and facilitated its degradation. This in turn reduced RAD51 expression, leading to an accumulation of DNA damage and decreased cell viability. Xenograft models further demonstrated that GW833972A treatment alone inhibited ARID1A-wt OCCC tumor growth. Together, our findings reveal an essential oncogenic role of BMAL2 and demonstrate that it is an appealing therapeutic target, especially for ARID1A-wt OCCC. Statement of significance: BMAL2 depletion, or degradation by a small molecule, led to DNA damage accumulation, decreased cell viability and reduced tumorigenesis of ARID1A-wildtype ovarian clear cell carcinoma, indicating that BMAL2 is an appealing therapeutic target for treating this malignant disease.
Open AccessBMAL2 is a druggable target for ARID1A-wildtype ovarian clear cell carcinoma (OCCC)
Ovarian clear cell carcinoma (OCCC) is highly chemo-resistant and has worse clinical outcome at advanced stages than other ovarian cancer subtypes. The most frequent (∼50%) alterations in OCCC are AT-rich interactive domain 1A gene (ARID1A) mutations which lead to ARID1A deficiency. However, OCCC that retains ARID1A function differs substantially from ARID1A mutated OCCC. Particularly, targeted therapies that sensitize ARID1A-deficient OCCC to DNA damage are largely ineffective against OCCC with wild-type (wt) ARID1A. Thus, it is important to identify druggable targets and develop targeted therapies specifically for ARID1A-wt OCCC. We identified BMAL2 as a critical OCCC oncogene that promotes tumorigenesis by preventing DNA damage from endogenous origins. BMAL2 depletion altered expression of genes in DNA damage repair pathways, including RAD51, a core enzyme of the homologous recombination (HR) pathway. This led to double-stranded break accumulation, decreased cell viability and reduced tumor growth. This dependence on BMAL2 to maintain DNA integrity and cell viability can be a new route to suppress ARID1A-wt OCCC. Consistent with this idea, we found that GW833972A, a cannabinoid receptor agonist, bound BMAL2 with high affinity and facilitated its degradation. This in turn reduced RAD51 expression, leading to an accumulation of DNA damage and decreased cell viability. Xenograft models further demonstrated that GW833972A treatment alone inhibited ARID1A-wt OCCC tumor growth. Together, our findings reveal an essential oncogenic role of BMAL2 and demonstrate that it is an appealing therapeutic target, especially for ARID1A-wt OCCC. Statement of significance: BMAL2 depletion, or degradation by a small molecule, led to DNA damage accumulation, decreased cell viability and reduced tumorigenesis of ARID1A-wildtype ovarian clear cell carcinoma, indicating that BMAL2 is an appealing therapeutic target for treating this malignant disease.
- Open Access
- 29 July 2025
- Published by American Society for Microbiology in mSphere
- Vol. 10  (7) , e0012425
Comprehensive analysis of repetitive extragenic palindrome sequences identified in bacteria and archaea using a new web-based tool, RepRanger
Repetitive extragenic palindromic (REP) sequences were first discovered in the intergenic regions of Escherichia coli and later found in phylogenetically distinct bacterial species. However, their biological roles and sequence conservation remain unclear. Considering the growing number of microbial genome sequencing and annotation projects, along with the lack of online tools for REP identification, we developed a new web-based platform, RepRanger, to rapidly identify and annotate putative palindromic elements, including REPs. Using RepRanger, we identified >4,000 REPs in the E. coli MG1655 genome. Moreover, 81 (~52%) of its 157 small noncoding RNAs (sRNAs; known to regulate gene expression) contain REPs. Further analysis using RepRanger, alongside other bioinformatics tools, yielded 10 REP consensus motifs. Notably, REPs potentially involved in translational control (i.e., located within 15 nucleotides downstream of an open reading frame) primarily host motif 4, whereas REPs present in sRNAs predominantly encoded motif 9. Putative targets of REP-containing sRNAs include genes that rewire metabolic pathways in response to environmental changes, indicating that REPs likely contribute to bacterial adaptation. We also reveal that REP consensus motifs are similar across pathogenic and environmental E. coli strains but not commensal and laboratory ones. We employed RepRanger to search for REPs and confirm that they are present across bacteria and archaea. Furthermore, we uncovered similarities in REP sequences between bacterial and archaeal genomes. Thus, we demonstrate that RepRanger represents a versatile tool for discovering REPs in bacteria and archaea, providing new insights into their functions and sequence diversity. IMPORTANCE: Repetitive extragenic palindromic (REP) sequences were first discovered in Escherichia coli , but their biological roles, diversity, and sequence conservation remain unclear. We have developed a web-based tool, RepRanger, to identify and annotate putative palindromic elements, including REPs. Using RepRanger, we identified approximately 4,000 REPs in the E. coli MG1655 genome. We show that >50% of small noncoding RNAs (sRNAs) contain REPs. The predicted functions of REP-containing sRNAs indicate that REPs likely contribute to bacterial environmental adaptability. In addition, we have discovered REPs in pathogenic, environmental, and commensal E. coli, allowing us to assess their sequence similarity. We show that REPs are widely present in bacterial and archaeal genomes and share some sequence similarities. Our comparison of REPs in annotated genomes broadens the current understanding of REP sequence diversity, conservation, and function.
- 29 July 2025
- Published by American Society for Microbiology in mSphere
- Vol. 10  (7) , e0012425
Open AccessComprehensive analysis of repetitive extragenic palindrome sequences identified in bacteria and archaea using a new web-based tool, RepRanger
Repetitive extragenic palindromic (REP) sequences were first discovered in the intergenic regions of Escherichia coli and later found in phylogenetically distinct bacterial species. However, their biological roles and sequence conservation remain unclear. Considering the growing number of microbial genome sequencing and annotation projects, along with the lack of online tools for REP identification, we developed a new web-based platform, RepRanger, to rapidly identify and annotate putative palindromic elements, including REPs. Using RepRanger, we identified >4,000 REPs in the E. coli MG1655 genome. Moreover, 81 (~52%) of its 157 small noncoding RNAs (sRNAs; known to regulate gene expression) contain REPs. Further analysis using RepRanger, alongside other bioinformatics tools, yielded 10 REP consensus motifs. Notably, REPs potentially involved in translational control (i.e., located within 15 nucleotides downstream of an open reading frame) primarily host motif 4, whereas REPs present in sRNAs predominantly encoded motif 9. Putative targets of REP-containing sRNAs include genes that rewire metabolic pathways in response to environmental changes, indicating that REPs likely contribute to bacterial adaptation. We also reveal that REP consensus motifs are similar across pathogenic and environmental E. coli strains but not commensal and laboratory ones. We employed RepRanger to search for REPs and confirm that they are present across bacteria and archaea. Furthermore, we uncovered similarities in REP sequences between bacterial and archaeal genomes. Thus, we demonstrate that RepRanger represents a versatile tool for discovering REPs in bacteria and archaea, providing new insights into their functions and sequence diversity. IMPORTANCE: Repetitive extragenic palindromic (REP) sequences were first discovered in Escherichia coli , but their biological roles, diversity, and sequence conservation remain unclear. We have developed a web-based tool, RepRanger, to identify and annotate putative palindromic elements, including REPs. Using RepRanger, we identified approximately 4,000 REPs in the E. coli MG1655 genome. We show that >50% of small noncoding RNAs (sRNAs) contain REPs. The predicted functions of REP-containing sRNAs indicate that REPs likely contribute to bacterial environmental adaptability. In addition, we have discovered REPs in pathogenic, environmental, and commensal E. coli, allowing us to assess their sequence similarity. We show that REPs are widely present in bacterial and archaeal genomes and share some sequence similarities. Our comparison of REPs in annotated genomes broadens the current understanding of REP sequence diversity, conservation, and function.
- Open Access
- 17 October 2024
- Published by Springer Nature in Research Square
Loss of PERIOD2 (PER2) induces HO-1-mediated epithelial-mesenchymal transition and cisplatin resistance in Epi-A ovarian cancer
Rapid metastasis and chemoresistance make ovarian cancer (OC) the deadliest gynecological cancer. These malignant phenotypes are strongly associated with epithelial-mesenchymal transition (EMT). OC is highly heterogenous with five distinct gene-expression based molecular subtypes (GEMS) correlated with different EMT levels and patient survival. However, the regulatory mechanisms underlying GEMS-specific EMT and malignancy remain unclear. We found that PER2 gene expression was significantly downregulated in OC compared to normal ovarian tissues. Among the five GEMS, PER2 expression was relatively high in the Epithelial-A (Epi-A) subtype and Epi-A OC patients with higher PER2 level had better overall survival. Notably, PER2 expression was required to maintain the epithelial phenotype. Conversely, PER2 depletion drove EMT and consequently enhanced migration and invasion ability of Epi-A OC cells via upregulation of Heme oxygenase-1 (HO-1). PER2 depletion also increased cisplatin resistance. Inhibition of HO-1 in PER2-depleted Epi-A OC cells impeded invasion and migration, and re-sensitized the cells to cisplatin. Our results revealed new insights into how an epithelial-like, less malignant OC subtype acquires EMT to become more invasive and chemoresistant. These findings also indicate that prevention of PER2 downregulation and targeting HO-1 are promising strategies for treating Epi-A OC progression.
- 17 October 2024
- Published by Springer Nature in Research Square
Open AccessLoss of PERIOD2 (PER2) induces HO-1-mediated epithelial-mesenchymal transition and cisplatin resistance in Epi-A ovarian cancer
Rapid metastasis and chemoresistance make ovarian cancer (OC) the deadliest gynecological cancer. These malignant phenotypes are strongly associated with epithelial-mesenchymal transition (EMT). OC is highly heterogenous with five distinct gene-expression based molecular subtypes (GEMS) correlated with different EMT levels and patient survival. However, the regulatory mechanisms underlying GEMS-specific EMT and malignancy remain unclear. We found that PER2 gene expression was significantly downregulated in OC compared to normal ovarian tissues. Among the five GEMS, PER2 expression was relatively high in the Epithelial-A (Epi-A) subtype and Epi-A OC patients with higher PER2 level had better overall survival. Notably, PER2 expression was required to maintain the epithelial phenotype. Conversely, PER2 depletion drove EMT and consequently enhanced migration and invasion ability of Epi-A OC cells via upregulation of Heme oxygenase-1 (HO-1). PER2 depletion also increased cisplatin resistance. Inhibition of HO-1 in PER2-depleted Epi-A OC cells impeded invasion and migration, and re-sensitized the cells to cisplatin. Our results revealed new insights into how an epithelial-like, less malignant OC subtype acquires EMT to become more invasive and chemoresistant. These findings also indicate that prevention of PER2 downregulation and targeting HO-1 are promising strategies for treating Epi-A OC progression.
- Open Access
- 21 August 2024
- Published by Springer Nature in Nature Communications
- Vol. 15  (1) , 1-18
Altered assembly paths mitigate interference among paralogous complexes
Protein complexes are fundamental to all cellular processes, so understanding their evolutionary history and assembly processes is important. Gene duplication followed by divergence is considered a primary mechanism for diversifying protein complexes. Nonetheless, to what extent assembly of present-day paralogous complexes has been constrained by their long evolutionary pathways and how cross-complex interference is avoided remain unanswered questions. Subunits of protein complexes are often stabilized upon complex formation, whereas unincorporated subunits are degraded. How such cooperative stability influences protein complex assembly also remains unclear. Here, we demonstrate that subcomplexes determined by cooperative stabilization interactions serve as building blocks for protein complex assembly. We further develop a protein stability-guided method to compare the assembly processes of paralogous complexes in cellulo. Our findings support that oligomeric state and the structural organization of paralogous complexes can be maintained even if their assembly processes are rearranged. Our results indicate that divergent assembly processes by paralogous complexes not only enable the complexes to evolve new functions, but also reinforce their segregation by establishing incompatibility against deleterious hybrid assemblies.
- 21 August 2024
- Published by Springer Nature in Nature Communications
- Vol. 15  (1) , 1-18
Open AccessAltered assembly paths mitigate interference among paralogous complexes
Protein complexes are fundamental to all cellular processes, so understanding their evolutionary history and assembly processes is important. Gene duplication followed by divergence is considered a primary mechanism for diversifying protein complexes. Nonetheless, to what extent assembly of present-day paralogous complexes has been constrained by their long evolutionary pathways and how cross-complex interference is avoided remain unanswered questions. Subunits of protein complexes are often stabilized upon complex formation, whereas unincorporated subunits are degraded. How such cooperative stability influences protein complex assembly also remains unclear. Here, we demonstrate that subcomplexes determined by cooperative stabilization interactions serve as building blocks for protein complex assembly. We further develop a protein stability-guided method to compare the assembly processes of paralogous complexes in cellulo. Our findings support that oligomeric state and the structural organization of paralogous complexes can be maintained even if their assembly processes are rearranged. Our results indicate that divergent assembly processes by paralogous complexes not only enable the complexes to evolve new functions, but also reinforce their segregation by establishing incompatibility against deleterious hybrid assemblies.
- Open Access
- 18 July 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52  (16) , 9551-9573
DNA cytosine methyltransferases differentially regulate genome-wide hypermutation and interhomolog recombination in Trichoderma reesei meiosis
Trichoderma reesei is an economically important enzyme producer with several unique meiotic features. spo11, the initiator of meiotic double-strand breaks (DSBs) in most sexual eukaryotes, is dispensable for T. reesei meiosis. T. reesei lacks the meiosis-specific recombinase Dmc1. Rad51 and Sae2, the activator of the Mre11 endonuclease complex, promote DSB repair and chromosome synapsis in wild-type and spo11Δ meiosis. DNA methyltransferases (DNMTs) perform multiple tasks in meiosis. Three DNMT genes (rid1, dim2 and dimX) differentially regulate genome-wide cytosine methylation and C:G-to-T:A hypermutations in different chromosomal regions. We have identified two types of DSBs: type I DSBs require spo11 or rid1 for initiation, whereas type II DSBs do not rely on spo11 and rid1 for initiation. rid1 (but not dim2) is essential for Rad51-mediated DSB repair and normal meiosis. rid1 and rad51 exhibit a locus heterogeneity (LH) relationship, in which LH-associated proteins often regulate interconnectivity in protein interaction networks. This LH relationship can be suppressed by deleting dim2 in a haploid rid1Δ (but not rad51Δ) parental strain, indicating that dim2 and rid1 share a redundant function that acts earlier than rad51 during early meiosis. In conclusion, our studies provide the first evidence of the involvement of DNMTs during meiotic initiation and recombination.
- 18 July 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52  (16) , 9551-9573
Open AccessDNA cytosine methyltransferases differentially regulate genome-wide hypermutation and interhomolog recombination in Trichoderma reesei meiosis
Trichoderma reesei is an economically important enzyme producer with several unique meiotic features. spo11, the initiator of meiotic double-strand breaks (DSBs) in most sexual eukaryotes, is dispensable for T. reesei meiosis. T. reesei lacks the meiosis-specific recombinase Dmc1. Rad51 and Sae2, the activator of the Mre11 endonuclease complex, promote DSB repair and chromosome synapsis in wild-type and spo11Δ meiosis. DNA methyltransferases (DNMTs) perform multiple tasks in meiosis. Three DNMT genes (rid1, dim2 and dimX) differentially regulate genome-wide cytosine methylation and C:G-to-T:A hypermutations in different chromosomal regions. We have identified two types of DSBs: type I DSBs require spo11 or rid1 for initiation, whereas type II DSBs do not rely on spo11 and rid1 for initiation. rid1 (but not dim2) is essential for Rad51-mediated DSB repair and normal meiosis. rid1 and rad51 exhibit a locus heterogeneity (LH) relationship, in which LH-associated proteins often regulate interconnectivity in protein interaction networks. This LH relationship can be suppressed by deleting dim2 in a haploid rid1Δ (but not rad51Δ) parental strain, indicating that dim2 and rid1 share a redundant function that acts earlier than rad51 during early meiosis. In conclusion, our studies provide the first evidence of the involvement of DNMTs during meiotic initiation and recombination.